SPRO vs TECH
Spero Therapeutics Inc (SPRO) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Spero Therapeutics Inc (SPRO) is a biotechnology company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported SPRO revenue for 2024-12-31 was $48.0M. Net income was -$68.6M. Revenue was down 53.8% from 2023-12-31 to 2024-12-31. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
SPRO currently screens at market cap $149.5M and trailing P/E 9.6. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the SPRO and TECH stock pages for the full models.
Not investment advice.